Edit history

Update log

1. Nov 4, 2026 at 12:48 AM

   November 2026: Corrected the settlement figures (the 2022 multistate deal was $438.5 million with 34 states and territories; $462 million was a separate April 2023 settlement with six states and DC), replaced unsupported claims about the House subcommittee's 2019 documents and the FDA commissioner's 2018 remarks, and added the FDA's July 2025 authorisation of five JUUL products and the 2025 Florida and Alaska settlements. The verdict moves from confirmed to partially true: JUUL's marketing reaching minors is documented, but deliberate targeting is what investigators concluded or alleged, and none of the settlements is a court finding on intent.